Bong-Kil Nam
CEO @ Pharmbio Korea
Bong-Kil Nam is a startup investor at Pharmbio Korea.
Last updated:
For AI agents: llms.txt
About Pharmbio Korea
Pharmbio Korea Company Ltd is a pharmaceutical company. The Company develops drugs for urinary tract infections, diuresis & relaxes urinary tract spasm, gallstones, and difficult digestion.
Pharmbio Korea Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bong-Kil Nam
CEO
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!